Federal award
TASSO INC.
W911QY20P0158
Contract
Obligated and Ceiling
- Obligated (net)
- $5,060,658.32
- Ceiling (potential value, not spending)
- $5,060,658.32
- Current value
- $5,060,658.32
- Gross positive obligations
- $7,510,658.32
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TASSO INC. · JF2AG84MNZ77
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- TASSO INC. · JF2AG84MNZ77
- Awarding agency
- Department of War · sub-agency 2100 · office W911SR
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- W911QY20P0158
- Award type code
- B
- Actions
- 10 · May 1, 2020 to Mar 22, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 22, 2023 | FY2023 | P00009 | B | −$2,450,000.00 | — |
| Mar 17, 2022 | FY2022 | P00008 | D | $10,658.32 | — |
| Apr 14, 2021 | FY2021 | P00007 | D | $0.00 | — |
| Jan 11, 2021 | FY2021 | P00006 | D | $0.00 | — |
| Dec 3, 2020 | FY2021 | P00005 | D | $0.00 | — |
| Aug 21, 2020 | FY2020 | P00004 | D | $0.00 | — |
| Jun 30, 2020 | FY2020 | P00003 | D | $0.00 | — |
| Jun 1, 2020 | FY2020 | P00002 | D | $0.00 | — |
| May 11, 2020 | FY2020 | P00001 | D | $0.00 | — |
| May 1, 2020 | FY2020 | 0 | — | $7,500,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.